Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Shares Issued (2016 - 2025)

Aethlon Medical (AEMD) has disclosed Shares Issued for 15 consecutive years, with -$1.8 million as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Shares Issued fell 3806.44% year-over-year to -$1.8 million, compared with a TTM value of $3.5 million through Mar 2025, up 167.69%, and an annual FY2025 reading of $3.5 million, up 167.69% over the prior year.
  • Shares Issued was -$1.8 million for Q1 2025 at Aethlon Medical, down from $1.8 million in the prior quarter.
  • Across five years, Shares Issued topped out at $17.5 million in Q2 2021 and bottomed at -$1.8 million in Q1 2025.
  • Average Shares Issued over 5 years is $3.5 million, with a median of $1.1 million recorded in 2023.
  • The sharpest move saw Shares Issued skyrocketed 888.94% in 2024, then plummeted 3806.44% in 2025.
  • Year by year, Shares Issued stood at $17.5 million in 2021, then crashed by 52.41% to $8.3 million in 2022, then plummeted by 97.76% to $186502.0 in 2023, then surged by 888.94% to $1.8 million in 2024, then tumbled by 200.0% to -$1.8 million in 2025.
  • Business Quant data shows Shares Issued for AEMD at -$1.8 million in Q1 2025, $1.8 million in Q4 2024, and $3.5 million in Q2 2024.